Clinical Trial Update: Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients

View source ↗

Summary

This clinical trial update summarizes the safety and feasibility findings of using ExAblate focused ultrasound to disrupt the blood-brain barrier in patients wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Malignant Glioma

Drugs mentioned

• Exablate

Snippet

Sponsor: InSightec | Conditions: Glioma, Malignant, Glioblastoma | Status: COMPLETED